Bionomics Ltd
ASX:BNO

Watchlist Manager
Bionomics Ltd Logo
Bionomics Ltd
ASX:BNO
Watchlist
Price: 0.01 AUD Market Closed
Market Cap: 13.5m AUD

Bionomics Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Bionomics Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Bionomics Ltd
ASX:BNO
Net Income (Common)
-AU$24.9m
CAGR 3-Years
-62%
CAGR 5-Years
-33%
CAGR 10-Years
-21%
Opthea Ltd
ASX:OPT
Net Income (Common)
-$162.8m
CAGR 3-Years
-21%
CAGR 5-Years
-71%
CAGR 10-Years
-41%
Mesoblast Ltd
ASX:MSB
Net Income (Common)
-$102.1m
CAGR 3-Years
-4%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
CSL Ltd
ASX:CSL
Net Income (Common)
$3B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
8%
Telix Pharmaceuticals Ltd
ASX:TLX
Net Income (Common)
AU$32.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Net Income (Common)
-AU$50.3m
CAGR 3-Years
-54%
CAGR 5-Years
-49%
CAGR 10-Years
-33%
No Stocks Found

Bionomics Ltd
Glance View

Market Cap
14.7m AUD
Industry
Biotechnology

Bionomics Ltd. is a clinical stage biopharmaceutical company. The firm is engaged in discovery and development of novel drug candidates focused on the treatment of central nervous system disorders. The firm's segment includes Drug discovery and development and Contract services. Drug discovery and development segment includes discovery, development, and commercialization of compounds to match a target product profile. Contract services segment includes provision of scientific services on a fee for service basis to both external and internal customers. Its product candidates include BNC210, BNC375, BNC101 and BNC105. The BNC210 provides treatment for anxiety disorders, co-morbid anxiety, and depression. The BNC375 is a molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease (AD).The Company operates in three geographical areas, such as Australia, France and United States of America.

BNO Intrinsic Value
Not Available

See Also

What is Bionomics Ltd's Net Income (Common)?
Net Income (Common)
-24.9m AUD

Based on the financial report for Dec 31, 2022, Bionomics Ltd's Net Income (Common) amounts to -24.9m AUD.

What is Bionomics Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-21%

Over the last year, the Net Income (Common) growth was -15%. The average annual Net Income (Common) growth rates for Bionomics Ltd have been -62% over the past three years , -33% over the past five years , and -21% over the past ten years .

Back to Top